Complementary and alternative medicine for cancer care in India: Basic and clinical perspective

Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs

Volumn , Issue , 2010, Pages 31-82

  Vaidya, Ashok D B ^a,b,c   Amonkar, Ashok J ^d   Bhatt, Narendra S ^e,f   Parikh, Purvish M ^g  

^a Genetic Research Centre India   (India)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

^d TATA MEMORIAL HOSPITAL   (India)

^e CRIA Care Pvt Ltd   (India)

^f Bharati Vidyapeeth   (India)

^g Kasturba Health Society   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873576840     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-0020-3_3     Document Type: Chapter

References (192)

1. Parikh PM, Gopal MD Introduction: paclitaxel-current concepts. Ind J Med Paed Oncol. 1994;15:7-8.
2. Satyavati GV, cited by Jayaraman KS. Break with tradition. Nature 2006;442:342-3.
3. Vaidya ADB. Reverse pharmacological correlates of Ayurvedic drug action. Ind J Pharmacol. 2006;38:311-15. (Pubitemid 44546365)
4. Chopra A, Doiphode V. Ayurvedic medicine: core concept, therapeutic principles and current relevance. Med Clin North Am. 2002;86:75-89. (Pubitemid 34027999)
5. Hartwell JL. Plants against cancer. A survey. Loydia 1967;30:379-463.
6. Hartwell JL. Plants against cancer. A survey. Loydia 1968;31:71-170.
7. Hartwell JL. Plants against cancer. A survey. Loydia 1969;32:247-96.
8. Hartwell JL. Plants against cancer. A survey. Loydia 1970;33:288-392.
9. Hartwell JL. Plants against cancer. A survey. Loydia 1971;34:386-438.
10. Hartwell JL, Abbott BJ Antineoplastic principles in plants: recent developments in the field. Adv Pharmacol Chemother. 1969;7:117-209.
11. Farnsworth NR, Kaas CJ An approach utilizing information from traditional medicine to identify tumour-inhibiting plants. J Ethnophamacol. 1981;3:85-99. (Pubitemid 11163672)
12. Hartwell JL. Plants used against cancer. Lawrence, MA: Quarterman Publications; 1982.
13. Cragg GM, Newman DJ Plants as a source of anti-cancer agents, in Ethnopharmacology. In: Elisabetsky E, Etkin NL, editors. Encyclopedia of life support systems (EOLSS), developed under the auspices of the UNESCO. Oxford, UK: Eolss Publishers; 2004/Rev. 2006 [http://www.eolss.net].
14. Cragg GM, Kingston DGI, Newman DJ, editors. Anticancer agents from natural products. Boca Raton, FL: Taylor and Francis; 2005. pp. 47-70.
15. Pandey G, Sharma M. Medicinal plants: better remedy for neoplasms. Ind Drugs 2006;43:869-74.
16. Redkar RG, Jolly CI Natural products as anticancer agents. Ind Drugs 2003;40:619-26. (Pubitemid 40012529)
17. Sahu M, Mishra LC Benign growths, cysts and malignant tumours (Chapter 16). In: Mishra LC, editor. Scienticfic basis for ayurvedic therapies. Boca Raton, FL: CRC Press; 2004. pp. 273-305.
18. Vaidya AB. The medical aspects of bhrign samhita. M.D. Dissertation, University of Mumbai; 1963.
19. Dewey DL. The identification of a cell culture inhibitor in a tumour extract. Cancer Lett. 1978;4:77-84. (Pubitemid 8290573)
20. Shanmuga V. Siddha's science of longevity and kalpa medicine. Chennai: Shakthinilayam; 1963. p. 168.
21. Parmar RK. Comparative study of Ayurveda inrelationto neoplastic lessons and its management by indigenous drugs. M.D. Thesis (Ayurveda). Institute of Medical Sciences, Banaras Hindu University, Varanasi, India; 1983.
22. Singh L. Response of poorvakarma in different types of cancer treatment. M.D. Thesis, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India; 1983.
23. Saxena A, Dixit S, Aggrarwal S., Seenu V, Prashad R, Bhusham S.M., Tranikanti V., Misra MC, Srivastava A. An ayurvedic herbal compound to reduce toxicity to cancer chemotherapy: a randomized controlled trial. Indian J Med Pediatr Oncol. 2008;29(2):11-8.
24. Rao M, Rao P, Kamath P.N., et al Reduction of cisplatin-induced nephrotoxicity by Cystone, a polyherbal Ayurvedic preparation, in C 57 BL/6 J mice bearing B16 F1 melanoma without reducing its anti-tumour activity. J Ethnopharmacol. 1999;68:77-81. (Pubitemid 29502462)
25. Smith DE, Salerno JW Selective growth inhibition of human malignant melanoma cell line by sesame oil in vitro. Prostagl. Leukot. Ess. Fatty Acids 1992;46:145-50.
26. Lee KH, Kim JH, Lim D.S., et al Antileukaemic and anti-mutagenic effects of di (2-ethylhexyl) phthalate isolated from aloe vera. J Pharma Pharmacol. 2001;45:253.
27. Agarwal KC, Parks RJ Forskolin: a potential anti-metastatic agent. Int J Cancer 1983;32:801.
28. Matsuda T, Kuroyanagi M, Sugiyama S., et al Cell differentiation-inducing diterpenes from Andrographic paniculata nees. Chem Pharm Bull. 1994;42:1216.
29. Dwivedi C, Abu-Ghazaleh A. Chemopreventive effects of sandalwood oil on skin papillomas in mice. Eur J Cancer Prev. 1997;6:399.
30. Jagetia GC, Baliga MS, Venkatesh P. Ginger (Zingiber officinale Rosc) a dietary supplement, protects mice against radiation-induced lethality: mechanism of action. Cancer Biother Radiopharma. 2004;19:422-35. (Pubitemid 39281334)
31. Vriddhajivak. Forward of Kashyap Samhita. Shashtri Girijashankar Mayashankar, translator. Ahemadebad: Sastu Sahitya Mudranalaya; 1970.
32. AYUSH (Ayurveda, Yoga, Unani, Siddha & Homoeopathy). Annual report 2006-07. India: Ministry of Health & Family Welfare, Government of India.
33. Madhav (Vaidya R. Parikh, translator). Madhav Nidan, Ahmedabad: San-stu Sahitya Mudranalaya; 1962.
34. Sushrut (Shashtri Kalidas Govindaji, translator). Sushrut Samhita, Ahemedabad: Sastu Sahitya Mudranalaya; 1965.
35. Agnivesha (Charaka & Drdhabala, revised). Charak Samhita, Viman Sthan, Varanasi: Chowkhamba Vidya Bhavan; 1962.
36. Bhavan's SPARC. Withania somnifera in selected medicinal plants of India. Mumbai: CHEMEXCIL; 1992. pp. 353-6.
37. Indian Herbal Pharmacopoeia. Mumbai: IDMA; 2002. pp. 467-78.
38. Gogte VM. Ayurvedic pharmacology and therapeutic uses of medicinal plants. Mumbai: Bhavan's SPARC; 2000. p. 301.
39. Vaidya ADB, Devasagayam TPA. Current status of herbal drugs in India: an overview. J Clin Biochem Nutr. 2007;41(1):1-11. (Pubitemid 47266167)
40. Aiyar KN, Kolammal M. Pharmacognosy of ayurvedic drugs of Kerala. Trivandrum: University of Kerala; 1964;13:31-3.
41. Bhava Misra (Murthy K, translator). Bhavaprakash (1500 A.D.). Varanasi: Krishnadas Academy; 2001;1:258.
42. Winters M. Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Altern Med Rev. 2006;11:269-77. (Pubitemid 46037128)
43. Vaidya AB. The medical aspects of Bhrign-Samhita. M.D. Dissertation, Mumbai: University of Mumbai; 1963.
44. Vaidya S. Asandh-Withania somnifera Jungleni Jadibutti. Ahmedabad: Samaldas; 1923. pp. 22-3.
45. Chopra A, Doiphode VV Ayurvedic medicine: core concept, therapeutic principles and current relevance. Med Clin North Am. 2002;86:75-89. (Pubitemid 34027999)
46. Vaidya ADB, Vaidya RA, Nagral SI Ayurveda and a different level of evidence: from Lord Macaulay to Lord Walton (1835-2001 A.D.). J Assoc Physicians India. 2001;49:534-7.
47. Kanthsuriswarji (Bhatt CN, translator). Hitopadesh. Vadodara: Lakshmivilas Press; 1897. p. 101.
48. Gupta GL, Rana AC Withania somnifera (Ashwagandha): a review. Pharmacog Rev. 2007;1:129-35.
49. Kaur K, Rani G, Widodo N., et al Evaluation of the anti-proliferative and anti-oxidative activities of leaf extract from in vivo and in vitro raised ashwagandha. Food Chem Toxicol. 2004;42:2015-20. (Pubitemid 39421502)
50. Jayaprakasan B, Zhang Y, Seeram N.P., et al Growth inhibition of human Tumour. Cell lines by withanolides from Withania somnifera leaves. Life Sci. 2003;74:125-32. (Pubitemid 37324225)
51. Mathur R, Gupta SK, Singh N, et al Evaluation of the effect of Withania somnifera root extracts on cell cycle and angiogenesis. J Ethnopharmacol. 2006;105:336-41.
52. Mohan R, Hammers HJ, Bargagna-Mohan P, et al. Withaferin Ais a potent inhibitor of angiogenesis. Angiogenesis 2004;7:115-22. (Pubitemid 39491728)
53. Singh DD, Dey CS, Bhutani KK Down regulation of p34 cdc 2 expression with aqueous fraction from Withania somnifera for a possible mechanism of anti-tumour and other pharmacological effects. Phytomedicine 2001;8:492-4. (Pubitemid 34052607)
54. Aggarwal BB. Nuclear factor kB: the enemy within. Cancer Cell 2004;6:203-8.
55. Ichikawa H, Takada Y, Shishodia S., et al Withnolides potentiate apoptosis, inhibit invasion and abolish osteoclastogenesis through suppression NFkB activation and NFkB-regulated gene expression. Mol Cancer Thor. 2006;5:1434-45. (Pubitemid 44070479)
56. Senthil V, Ramadevi S, Venkata-Krishnan V, et al Withanolide induces apoptosis in HL-60 leukemia cells via mitochondria mediated cytochronic C release and carpase activation. Chem Biol Interact. 2007;167:19-30. (Pubitemid 46431216)
57. Devi PU, Sharda AC, Solomon FE Anti-tumour and radiosensitizing effects of Withania somnifera ashwagandha on a tramplantable mouse tumour Sarcoma, 180. Ind J Exp Biol. 1993;31:607-11.
58. Devi PU, Akagi K, Ostapenko V., et al Withaferin A: a new radiosensitizer from the indian medicinal plant withania somnifera. Int J Radiat Biol. 1996;69:193-7. (Pubitemid 26139626)
59. Devi PU, Karmath R. Radiosensitizing effect of withania A combined with hyperthermia on mouse fibosarcoma and melanoma. J Radiat Res. 2003;44:1-6. (Pubitemid 38738748)
60. Prakash J, Gupta SK, Kochapillai V, et al Chemopreventive activity of Withania somnifera in experimentally induced fibrosarcoma tumours in Swiss albino mice. Phytother Res. 2001;15:240-4. (Pubitemid 32458632)
61. Davis L, Kuttan G. Effect of Withania somnifera on DMBA-induced Carcinogenesis. J Ethnopharmacol. 2001;75:165-8. (Pubitemid 32297728)
62. Mathur S, Kaur R, Sharma M., et al The treatment of skin carcinoma induced by UVB radiation, using 1-oxo-5beta 6 beta-epoxy-with a-2-enolide, in a rat model. Phytomedicine 2004;11:452-60. (Pubitemid 38980527)
63. Christina AJ, Joseph DG, Pakialakshmi M, et al Anticarcinogenic activity of Withania somnifera Dunal against Dalton's ascetic lymphoma. J Ethnopharmacol 2004;93:359-61. (Pubitemid 38962429)
64. Leyon PV, Kuttan G. Effect of Withania somnifera on B 16-10 melanoma induced metastases in mice. Phytother Res. 2004;18:118-22. (Pubitemid 38380604)
65. Gupta YK, Sharma SS, Raj K, et al Reversal of paclitaxel-induced Neutropenia by Withania somnifera in mice. Indian J Physiol Pharmacol. 2001;45:253-7. (Pubitemid 32520050)
66. Diwanay S, Chitre C, Patwardhan B. Immunoprotection bybotanical drugs in cancer chemotherapy. J Ethnopharmacol. 2004;90:49-55. (Pubitemid 38091685)
67. Vaidya R. Vanaushadhi Shatak (Hindi). Varanasi: Sarva Seva Sangha; 1978. pp. 129-30.
68. Sharma PV. Recommended uses of Ayurvedic drugs. Anubhoot prayoga ratnakara. Vijaygadh: Sudhanidhi; 1964. pp. 67-8.
69. Sharma NP. Strength with ashwagandha. Anubhoot prayoga ratnakara. Vijaygadh: Sudhanidhi; 1964. pp. 284-5.
70. Shastri OP. Some gems of medicinal plants in practice. Anubhoot prayoga ratnakara. Vijaygadh: Sudhanidhi; 1964. pp. 280-1.
71. Shah BG. Ashwagandha, Ayurveda Vigyan. 1926;10:135-46.
72. Vyas MB. Shodhals location and period. Vaidya Kalpataru. 1918;23:234-7.
73. Dr. Brahmanand Nayak (editor-in-chief). Ayurvedline™. 9th ed. Bangalore: Dr. Seetharam Prasad; 2007. pp. 606-8.
74. SPARC. Selected medicinal plants of India. Mumbai: CHEMEXCIL; 1992. pp. 319-322.
75. Vaidya B. Guduchivarga. In: Nighantu Adarsha 2/48. 2nd ed. Varanasi: Chaukhamba Bharati Academy; 1998. p. 36.
76. Panchabhai TS, Kulkarni UP, Rege NN Validation of therapeutic claims of Tinospora cordifolia: a review. Phytother Res. 2008;22:425-41. (Pubitemid 351613406)
77. Sharma DNK, Khosla RL Chemistry and pharmacology of Tinospora cordifolia. Miers Ind Drugs 1993;30:549-54.
78. Indian Herbal Pharmacopoeia. 2nd ed. Mumbai: IDMA; VII, 2002. pp. 449-58.
79. Geogte VM. Medicinal plants (Part II). In: Ayurvedic pharmacology and therapeutic uses of medicinal plants. Mumbai: Bhavan's SPARC; 2000. pp. 359-61.
80. Gupta SS, Verm SCL, Garg VP, et al Anti-diabetic effect of T. cordifolia. Part 1. Effect on fasting blood sugar level, glucose tolerance and adrenaline-induced hyperglycemia. Indian J Med Res. 1967;55: 733-45.
81. Mathew S, Kuttan G. Antioxidant activity of Tinospora cordifolia and its usefulness in amelioration of cyclophosphamide-induced toxicity. J Exp Clin Cancer Res. 1997;16:407-11. (Pubitemid 28083542)
82. Dahanukar SA, Thatte UM, Pai N, Karandikar S.M., et al Therapeutic modification by Tinospora cordifolia of abdominal sepsis induced by caccal ligation. Indian J Gastrocaterol. 1988;7:21-3. (Pubitemid 18017047)
83. Sainis KB, Ramakrishnan R, Supariwala P.F., et al Further studies on immunoniodulation by natural products from Tinospora cordifolia. In: Upadhyay SN, editor. Immunopharmacology: strategies for immunotherapy. Delhi: Narosa publishing House; 1999. pp. 96-104.
84. Sarma DNK, Koshla RL, Chansuria JPN, et al Antistress activity of Tinospora cordifolia and Centella asiatica extract. Phyther Res. 1996;10:181-3. (Pubitemid 26103671)
85. 4-induced liver damage. Indian Drugs 1984;21:544-5.
86. Pendse VK, Mahavir MM, Khanna N.K., et al Anti-inflammatory and related activity of water extract of Tinospora cordifolia, 'Neem Giloe'. Indian Drugs 1981;19:14-21.
87. Nayampalli SS, Ainapure SS, Samant B.D., et al A comparative study of diuretic effects of Tinospora cordifolia and hydrochlorothiazids in rats and a preliminary phase 1 study in human volunteers. J Postgrad Med. 1988;34:233-8.
88. Agrawala A, Malini S, Baviry K.L., et al Effect of Tinospora cordifolia on learning and memory in normal and memory-deficit rats. Indian J Pharmacol. 2002;34:339-49. (Pubitemid 35173967)
89. Thatte UM, Chabria SN, Karandikar S.M., et al Protective effects of Indian medicinal plants against cyclophosphamide neutropenia. J Post Grad Med. 1987;33:185-8.
90. Diwaney S, Chitre D, Patwardhan B. Immuno-protection by botanical drugs in cancer chemotherapy. J Ethnopharmacol. 2004;90:49-55. (Pubitemid 38091685)
91. Pahadia S, Sharma J. Alteration of lethal effects of gamma rays in swiss albino mice by Tinospora cordifolia. Phytother Res. 2003;17:552-4. (Pubitemid 36605912)
92. Jogetia GC, Nayak V, Vidyasagar MS Evaluation of antineoplastic activity of guduchi (Tinospora cordifolia) in cultured HeLa cells. Cancer 1998;127:71-82. (Pubitemid 28230787)
93. Jagetia GC, Rao SK Evaluation of the antineoplastic activity of guduchi (Tinospora cordifolia) in Ehrlich ascites carcinoma bearing mice. Biol Pharm Bull. 2006;29:460-6.
94. Leyon PV, Kuttan G. Effect of Tinospora cordifolia on the cytokine profile of angiogenesis-induced animals. Int Immunopharmacol. 2004;4:1569-75. (Pubitemid 39348855)
95. Chintalwar G, Jain A, Sipahimalani A., et al An immunologically active arabinogalactan from Tinospora cordifolia. Phytochemistry 1999;52:1089-93. (Pubitemid 30016470)
96. Chauhan K. Successful treatment of throat cancer with Ayurvedic drugs. Sachitra Ayurveda 1995;47:840-2.
97. Vaidya A, Vaidya R, Vaidya V., et al Spontaneous regression or induced regression of cancer: a novel research strategy for Ayurvidya. Ancient Sci Life 2003;22:75-83.
98. Oak M. Efficacy of Tinospora cordifolia in reducing cytotoxic chemotherapy-induced leukopenia. M.D. (pharmacology) Thesis, University of Mumbai, Mumbai; 2001.
99. Vaingankar JA. Evaluation of Indian medicinal plants for immunoregulatory properties. M.Sc. (Applied Biology) Thesis, University of Mumbai, Mumbai; 2001.
100. Sharma PC, Yelne MB, Dennis TJ Data based on medicinal plants used in Ayurveda. New Delhi: CCRAS Publication. Vol. 5, pp. 9-28.
101. Gogte VM. Dravyagunvigyan. Bhavan's SPARC: Mumbai; 2000; p. 444.
102. Vaidya BG. NighantuAdarsh, 2nd ed. Varanasi: Chowkhambha Bharti Academy; 1998. Vol. 1, p. 314.
103. Raut Ashwini Kumar A, Sawant NS, Badre AS, et al. Bhallatak (Semecarpus anacardium Linn.)-a review. Indian J Tradit Knowl. 2007; 6 (4):653-9.
104. Goudgaon NM, Lambture JB, Nayak VR Semecarpus anacardium as an anticancer agent: epoxy derivatives of the monoene and dienebhilwanols. Indian Drugs 1984;22(11):556.
105. Gill RR, Lin LZ, Cordell G.A., et al Anacardoside from seeds of Semecarpus anacardium. Phytochemistry 1995;39(2):405-7.
106. Murthy SSN. Jeediflavanone-A, bioflavonoid from Semecarpus anacardium. Phytochemistry 1985;24(5):1065.
107. Sharma S. Rastarangini by P. Kashinath Shastri Commentary by Shri. Haridatta Shastri. Varanasi: Motilal Banarasidas; 1975. p. 735.
108. Agnivesha, Charak Samhita, 2nd ed. by Pandey G. Commentary by Shastri K. Varanasi: R D Chaukhambha Sanskrit Sansthan; 1983. Vol. 2, p. 22.
109. Sushrut, Sushrut Samhita by Acharya YT. Commentary by Dalhana, 7th ed. Varanasi: Chaukambha Orientaliya; 2002; p. 434.
110. Translated by board of scholars, Vaghbhatta Astang hridaya, 1st ed. Delhi: Sri Satguru Publications; 1991; Vol. 3, p. 331.
111. Indap MA, Ambaye RY, Gokhale SV Anti-tumour activity and pharmacological effects of the oil from Semecarpus anacardium Linn. Indian J Physiol Pharmacol. 1983;27(2):83.
112. Gothoskar SV, Randive KG Anti-cancer screening of SAN-AB and an extract of marking nut of Semecarpus anacardium. Indian J Exp Biol. 1971;9(3):39.
113. Gothoskar SV, Chitnis MP, Advankar M.K., et al Anti-tumour activity of SAN-AB, and an extract of marking nut of Semecarpus anacardium. Indian J Exp Biol. 1971;9(3):372-375.
114. Chitnis MP, Bhatia KG, Phatak M.K., et al Anti-cancer activity of the extract of Semecarpus anacardium L. nuts in experimental tumour model. Indian J Exp Biol. 1980;18(1):6.
115. Phatak MK, Ambaye RY, Indap M.A., et al. Cytotoxicity of the acelytated oil of Semecarpus anacardium Linn. Indian J Physiol Pharmacol. 1983;27(2):166.
116. Indap MA, Ambaye RY, Gokhale SV Potentiation of activity of anticancer drugs by acetylated oil of Semecarpus anacardium Linn in experimental tumour. Indian Drugs 1986;23(8):447.
117. Hembree JA, Chang CJ, McLaughlin J.L., et al The anticancer activity of Semecarpus anacardium. 9 K B active pentadecylaccatechols. Loydlia 1978;41(5):491.
118. 1 mediated hepatocellular carcinoma bearing Wistar rats with reference to tumour marker enzymes. Phytotherapy Res. 1999;13(3):183-7. (Pubitemid 29229442)
119. Mathivadhani P, Shanti P, Sadakandam P. Effect of Semecarpus anacardium Linn milk extract on glutathione and its associated enzymes in experimentally induced mammary carcinoma. J Med Food 2006;9(2):265.
120. Chakraborty S, Roy M, Taraphdar A.K., Bhattacharya RK Cyto-toxic effect of root extract of Tiliacora recemosa and oil of Semecarpus anacardium Linn nuts in human tumour cells. Phytother Res. 2004;18(8):595.
121. Soumyalakshmi S, Nur-E-Alam M, Akbharsha MA, et al. Investigation on S. Lehyam a sidhha medicine on breast cancer. Planta Medica 2005; 220 (6):910.
122. Kothari AB, Lahiri M, Ghaisas S.D., et al In vitro studies on anti-mutagenicity of water, alcohol and oil extracts of Semecarpus anacardium. Indian J Pharmacol. 1997;29(5):301.
123. Nair A, Bhide SV Anti-microbial properties of different parts of Semecarpus anacardium. Indian Drugs 1996;33(7):323-8. (Pubitemid 26394326)
124. Ramprasath VR, Shanti P, Sachdanandam P. Anti-inflammatory effect of Semecarpus anacardium Linn nut extract in acute and chronic inflammatory conditions. Bio Pharm Bull. 2004;27(12):2028.
125. Ramprasath VR, Shanti P, Sachdanandam P. Anti-inflammatory effect of Semecarpus anacardium Linn nut extract in acute and chronic inflammatory conditions. Bio Pharm Bull. 2006;29(4):693.
126. Tripathi YB, Singh AV Effect of Semecarpus anacardium nuts on lipid peroxidation. Indian J Exp Biol. 2001;39(8):798.
127. Selvam C, Jachak SM, Bhutani KK A cyclo-oxygenase (cox) inhibitory flavonoids from the seeds of Semecarpus anacardium Linn. Phytotherapy Res. 2004;18(7):582.
128. Selvam C, Jachak SM A cyclo-oxygenase (cox) inhibitory biflavonoid from the seeds of Semecarpus anacardium. J Ethnopharmacol. 2004;95 (2-3):209.
129. Prasad GC. Studies on cancer in Ayurveda and its management. J Rob Auton Syst. 1987;3:147-67.
130. Vad BG. Semecarpus anacardium clinical studies and animal experimentation showing anti-cancer properties on nuts and seeds of this indigenous plant. Bombay: Bombay Pharmaceutical Works Pvt Ltd; 1975.
131. Patwardhan BK, Saraf MN, David SB Toxicity of Semecarpus anacardium extract. Ancient Sci Life 1988;8(2):106.
132. Keshava Rao K.V., Gothaskar SV, Chitnis M.P., et al. Toxicological study of Semecarpus anacardium nut extract. J Physiol Pharmacol. 1979;23(2):115.
133. Vaishnav R, Shankanarayanan A, Chowdhary R.R., et al Toxicity studies on a proprietary preparation of Semecarpus anacardium. Indian J Med Res. 1983;77:106.
134. Vijayalakshmi T, Muthulakshmi V, Sachdanandam P. Toxicity studies on biochemical parameters carried out in rats with serankottari nei, Siddha drug milk extract of Semecarpus anacardium nut. J Ethanopharmacol. 2000;69(1):9.
135. Vaidya Gogte VM. Ayurvedic pharmacology and therapeutic uses of medicinal plants. Dravyaguna Vigyan: Bharatiya Vidya Bhavan's SPARC; 2000. pp. 514-15.
136. Sharma PC, Yelne MB, Jennis TJ Data base on medicinal plants used in Ayurveda. New Delhi: CCRAS Publications; 2000. Vol. 1, pp. 132-55.
137. Amon HP, Wahi MA Pharmacology of Curcuma longa. Planta Medica 1991;57:1-7.
138. Rao TS, Basu N, Siddiqui HH Anti-inflammatory activity of curcumin analogues. Indian J Med Res. Apr 1982;75:574-8. (Pubitemid 13226183)
139. Chattopadhyay I, Biswas K, Bandopadhyay U., et al Turmeric and curcumin: biological actions and medical applications. Curr Sci. 2004;87(1):44-54.
140. Chemical Constituents of Haridra. mhtml:file//g:\Haridra\ Chemicals%20Constituents%20of%20Turmeric.mht. 2008.
141. 2 production. Cancer Res. 2001;(61):1058-64. (Pubitemid 32174425)
142. Khopde SM, Priyadarsini KI, Guha S.N., et al Inhibition of radiationinduced lipid peroxidation by tetrahydrocurcumin: possible mechanisms by pulse radiolysis. Biosci Biotechnol Biochem. 2000;(64):503-9.
143. Pari L, Murugan P. Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. Pharmacol Res. 2004;49:481-6. (Pubitemid 38292207)
144. Pari L, Amali RD Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats. J Pharm Sci. 2005;(8):115-23. (Pubitemid 41528877)
145. Kalathil N, Tava Aldo, Shafi PM, et al Chemical compositions of essential oils of turmeric (Curcuma longa). Acta Pharm. 2002;52:137-41. (Pubitemid 34773843)
146. Behura S, Sahoo S, Srivastava VK Major constituents of leaf essential oils of Curcumin longa and Curcuma salisb. Curr Sci. 2002;83(11):1312-13.
147. K.W. Quirlh Flaven Naturextrakte GmbH. Nutraceuticals. New Spring, 2002; 26-29.
148. Gonda R, Tomoda M, Shimizu N., et al Characterization of polysaccharides having activity on the reticuloendothelial system from the rhizome of Curcuma longa. Chem Pharm Bull. 1990;38(2):482-6. (Pubitemid 20161722)
149. Gonda R, Tomoda M, Takada K., et al The core structure of ukonan A, a phagocytosis activating polysaccharide from the rhizome of Curcuma longa and immunological activities of degradation products. Chem Pharm Bull. 1992;40(4):990-3.
150. Gonda R, Takada K, Shimizu N., et al Characterization of neutral polysaccharide having activity on the reticuloendothelial system from the rhizome of Curcuma longa. Chem Pharm Bull. 1992;40(1):185-8.
151. Gonda R, Tomoda M, Ohara N., et al Arabinogalactan core structure and immunological activities of ukonan C, an acidic polysaccharide from the rhizome of Curcuma longa. Chem Pharm Bull. 1993;16(3):235-8. (Pubitemid 23142892)
152. Bhalchandran P, Rajgopal G. Cancer an Ayurvedic prospective. Pharmacol Res. 2005;51:19-30.
153. Bhavmisra. Madhya and Uttarkhanda. Murthy KRS, Bhavprakash. Varanasi: Krishna's Academy; 2001. Vol. 2.
154. Vaidya Ambikadatta Shastri. Bhaishyajya Ratnawali. 11th rev. ed, 997. Varanasi: Choukhamba Prakashan; 2007.
155. Singhal GD, Singh LM The management of glandular swellings, cervical lymphadenopathy, tumours and goiters. In: Singhal GD, Singh LM, editors. Operative considerations in ancient Indian surgery based on Susruta Samhita, Chikitsa sthana. Varanasi: Singhal Publications; 1982. pp. 339-56.
156. www.cancercliniconline.com
157. Ghatak, Basu N. Sodium curcuminate as an effective anti-inflammatory agent. Indian J Exp Biol. 1970;17:1363-6.
158. Shrihari Rao T., Basu N, Siddiqui HH Anti-inflammatory activity of curcumin analogues. Indian J Med Res. 1982;75:574-8. (Pubitemid 13226183)
159. Shrivastava R, Srimal RC Modification of certain inflammation induced biochemical changes by curcumin. Indian J Med Res. 1985;81:215-23.
160. Brouet I, Ohshima H. Curcumin an anti-tumour promoter and antiinflammatory agent inhibits induction of nitric oxide synthase in activated microphages. Biochem Biophys Res Commun. 1995;206:533-40.
161. Costa B, Bettoni I, Petrosino S., Comelli F, Giagnoni G, Di Marzo V. The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice. Pharmacol Res. 2010;61(6):537-46.
162. Yegnarayanan R, Saraf AP, Bhalwani JH Comparison of anti-inflammatory activity of various extracts of Curcuma longa Linn. Indian J Med Res. 1976;64:601-8.
163. Ramchandran R, Bhide SV, Ghaisas S.D., et al Anti-inflammatory activity of turmeric oil in arthritis in model in rat. Proceedings of the International Conference on 'Ayurveda 2000', Chennai, pp. 199-200.
164. Mishra N, Gupta SS Anti-inflammatory and anti-hyaluronidase activity of volatile oil of Curcuma longa. J Res Ayur Siddha 1997;1-2(18):56-62.
165. Iyergar MA, RamaRao MP, Gurumedhava R, et al Anti-inflammatory activity of volatile oil of Curcuma longa leaves. Indian Drugs 1994; 31 (2):528-31.
166. Guddadarangavvanahally KJ, Jena BS, Negi P.S., et al Evaluation of antioxidant and anti-mutagenicity of turmeric oil: a byproduct of curcumin production Z. Naturnaforsch. 2002;57C:828-35. (Pubitemid 35280746)
167. Lee HS. Anti-platelet property of Curcuma longa Linn rhizome derived arturmerone. Bioresource Tech. 2000;97(12):1372-6.
168. Nagbhushan M, Amonkar AJ, Bhide SV In vitro anti-mutagenicity of curcumin against environmental mutagens. Fd Chem Tox. 1987;25(5):545-7. (Pubitemid 17135311)
169. Nagbhushan M, Nair UJ, Amonkar A.J., et al Curcumins as inhibitors of nitrosation in vitro. Mutat Res. 1988;202:163-9.
170. Selvan R, Subramanium L, Gayatri R., et al Anti-oxidant activity of turmeric (Curcuma longa). J Ethanopharmacol. 1995;47(2):59-67.
171. Anto RJ, Kuttan G, Babu SVD, et al A comparative study on the pharmacological properties of natural curcuminoids. Amla Res Bull. 1999;14:60-5.
172. Scartezzini P, Speroni E. Review on some medicinal plants of Indian traditional medicine with anti-oxidant activity. Biochem Pharmacol. 1999;52(4):519-25.
173. Reddy Ach Pulla, Lokesh BR. Studies on spice principles as anti-oxidant in the inhibition of lipid-peroxidation of rat liver microsomes. Mol Cell Biochem. 1992;111:117-24.
174. Sharma OP. Anti-oxidant activity of curcumin and related compounds. Biochem Pharmacol. 1976;25:1811-12.
175. Ruby AJ, Kuttan G, Babu K.D., et al Anti-tumour and anti-oxidant activity of natural cucuminoids. Cancer Lett. 1995;99(1):79-83.
176. Srinivas L, Shalini VK, Shylaja M. Turmerin and water soluble antioxidant peptide from turmeric (Curcuma longa). Arch Biochem Biophys. 2004;292(2):617-23.
177. Agarwal BB, Kumar A, Bharati AC Anticancer potential of curcumin, preclinical and clinical studies. Anticancer Res. 2005;23:363-98.
178. Ramchandran C, et al Curcumin inhibits telomerase activity through telomerase reverse transcriptase in MCF-7 breast cancer cell line. Cancer Lett. 2002;184:1-6.
179. Goel A, Boland CR, Chauhan DP Specific inhibitionofcyclo-oxygenase 2 (COX-2) expression by dietary curcumin HT 29 Human colon cancer cell. Cancer Lett. 2001;172:111-18. (Pubitemid 32889704)
180. Khan A, Ali AM, Pardhasaradhi B.V., et al Anti-tumour activity of curcumin is mediated through the induction of apoptosis in AK-5 tumour cells. FEBS Lett. 1999;445:165-8. (Pubitemid 29101554)
181. Somasundaram S, et al Dietary curcumin inhibits chemotherapy induced apoptosis in models of human breast cancer. Clin Cancer Res. 2001;7: 2895-900.
182. Mahadey GB, Perdland SL, Yun G, et al Turmeric (Curcuma longa) and curcumin inhibits the growth of Helicobeter pylori of group 1 carcinogen. Anticancer Res. 2002;22:4179-81. (Pubitemid 36134453)
183. Sharma RA, Gescher AJ, Steward WP Curcumin the story so far. Exp J Cancer 2005;41:1955-68.
184. Bhavani Shankar T.N., Santha NV, Ramesh H.P., et al Toxicity studies of on turmeric (Curcuma longa) acute toxicity studies in rats, guinea pigs and monkeys. Indian J Exp Biol. 1980;18:73-5. (Pubitemid 10143537)
185. Sambaiah K, RatanKumar S, Kamanna V.S., et al Influence of turmeric and curcuma on growth, blood constituents and serum enzymes in rats. J Food Sci Technol. 1982;19:187-90.
186. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin, a component of turmeric (Curcuma longa). J Altern Complement Med. 2003;9:161-8. (Pubitemid 36297021)
187. Joshi JV, Ghaisas S, Vaidya A., et al Early human safety study of turmeric oil (Curcuma longa oil) administered orally in healthy volunteers. J Assoc Physicians India 2003;51:1055-60. (Pubitemid 41279813)
188. Satoskar RR, Shah SJ, Shenoy SG Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol. 1986;24(12):651-4. (Pubitemid 17205963)
189. Kuttan R, Sudheeran PC, Joseph CD Turmeric and curcumin as topical agents in cancer therapy. Tumouri 1987;73(1):29-31. (Pubitemid 17034485)
190. Chang AL, et al Phase I clinical trials of curcumin a chemopreventive agents in patients with high risk of pre-malignant lesions. Anticancer Res. 2001;21:2895-900.
191. Sharma RA, et al Pharmacodynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer. Clin Cancer Res. 2001;7:1844-900.
192. Hastak K, Lubri N, Jakhi S., et al Therapeutic effect of turmeric oil and turmeric oleoresin in oral sub mucous fibrosis (SMF) in patients. Cancer Lett. 1997;116:265-9. (Pubitemid 27283017)